Active substance
Results for the substance bedaquiline
1 result
About this active substance
Bedaquiline is a medication used for the treatment of multidrug-resistant pulmonary tuberculosis (MDR-TB), in combination with other antitubercular drugs. It works by inhibiting mycobacterial ATP synthase, an enzyme essential for energy production in Mycobacterium tuberculosis.
The medication is taken orally, usually once daily, as directed by a doctor. The treatment requires close monitoring to assess efficacy and prevent the development of resistance.
Common side effects include nausea, joint pain, headache, and elevated liver enzyme levels. In rare cases, more severe adverse effects such as cardiac arrhythmias or hepatotoxicity may occur.
Bedaquiline is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.
The medication is taken orally, usually once daily, as directed by a doctor. The treatment requires close monitoring to assess efficacy and prevent the development of resistance.
Common side effects include nausea, joint pain, headache, and elevated liver enzyme levels. In rare cases, more severe adverse effects such as cardiac arrhythmias or hepatotoxicity may occur.
Bedaquiline is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.